Complete Filing Data
Glucose Health, Inc. reported Operating Expenses of $105.8 thousand for FY2016.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Glucose Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$410.4K | -$266.1K | -$669.4K | -$1.5M | -$399.1K | -$899.2K | -$632.7K |
| Cost of Revenue * | $294.1K | $3.9K | $2.6K | $2.3K | $3.4K | ||
| Operating Expenses | $105.8K | $156.6K | $524.5K | $1.3M | $361.4K | $888.8K | $613.9K |
| General And Administrative Expense | $51.8K | $114.8K | $16.3K | $39.5K | $5.8K | $14.7K | $39.7K |
| Operating Income Loss | -$86.6K | -$156.2K | -$545.2K | -$1.3M | -$361.4K | -$888.8K | -$614.8K |
| Nonoperating Income Expense | -$323.8K | -$109.9K | -$124.2K | -$189.9K | -$37.7K | -$10.4K | -$17.9K |
| Interest Expense | $323.8K | $120.0K | $109.6K | $168.9K | $37.7K | $10.4K | $17.9K |
| Gross Profit | $19.2K | $397.00 | -$20.7K | -$2.1K | -$947.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$410.4K | -$266.1K | -$669.4K | -$1.5M | -$399.1K | ||
| Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $371.2K | $150.3K | $534.1K | $1.3M | $315.4K | $875.9K | $523.1K |
| Sales Revenue Goods Net | $313.2K | $4.3K | $2.7K | $224.00 | $2.4K | ||
| Comprehensive Income Net Of Tax | -$1.5M | -$405.1K | -$900.4K | -$659.5K | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$6.1K | -$1.2K | -$26.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $18.8K | $49.3K | -$29.0K | -$160.8K | -$87.4K | -$29.3K | -$49.3K | -$50.0K | -$120.0K | -$104.4K | -$102.5K | -$46.4K | -$146.6K | -$344.6K | -$235.7K | -$282.9K | -$184.6K | -$7.7K | -$176.1K | -$161.7K | -$109.6K | -$54.3K |
| Cost of Revenue * | $790.00 | $272.00 | $14.6K | $4.7K | $274.5K | $60.00 | $2.0K | $340.00 | $2.1K | $9.3K | $1.0K | $13.1K | -$874.00 | -$2.1K | $3.4K | |||||||
| Operating Expenses | $18.4K | $17.7K | $28.8K | $52.9K | $15.3K | $12.3K | $34.3K | $42.6K | $64.7K | $64.2K | $71.3K | $39.0K | $220.2K | $285.6K | $192.5K | $209.0K | $21.3K | $7.0K | $161.3K | $106.4K | $48.5K | |
| General And Administrative Expense | $4.7K | $7.6K | $12.5K | $36.4K | $5.8K | $2.9K | $23.2K | $9.1K | $3.4K | $984.00 | $7.9K | $5.4K | $5.6K | $3.3K | $9.2K | $632.00 | $3.2K | $1.3K | $4.3K | $5.1K | $21.1K | |
| Operating Income Loss | $4.6K | $16.1K | -$28.3K | -$55.6K | $6.0K | -$12.3K | -$34.2K | -$42.4K | -$64.7K | -$64.1K | -$80.2K | -$39.9K | -$233.1K | -$285.6K | -$192.5K | -$209.0K | -$21.3K | -$7.0K | -$160.4K | -$104.4K | -$49.4K | |
| Nonoperating Income Expense | $14.1K | $33.2K | -$696.00 | -$105.3K | -$93.4K | -$17.0K | -$15.1K | -$7.6K | -$55.3K | -$40.3K | -$22.3K | -$6.5K | $86.5K | -$59.1K | -$43.2K | -$74.0K | -$163.3K | -$734.00 | -$1.3K | -$5.2K | -$4.9K | |
| Interest Expense | $5.7K | $5.1K | $696.00 | $105.3K | $93.4K | $17.0K | $15.1K | $28.2K | $55.3K | $40.3K | $22.3K | $6.5K | -$107.5K | $59.1K | $43.2K | $74.0K | $163.3K | $734.00 | $1.3K | $5.2K | $4.9K | |
| Gross Profit | $23.0K | $33.8K | $473.00 | -$2.6K | $21.3K | $60.00 | $105.00 | $212.00 | $25.00 | $133.00 | -$8.8K | -$953.00 | -$12.9K | $874.00 | $2.1K | -$947.00 | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $18.8K | $49.3K | -$29.0K | -$160.8K | -$87.4K | -$29.3K | -$49.3K | -$50.0K | -$120.0K | -$104.4K | -$102.5K | -$46.4K | -$146.6K | -$344.6K | -$235.7K | |||||||
| Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $17.5K | -$19.3K | $50.9K | $45.7K | $185.4K | $6.7K | $101.6K | |||||||||||||||
| Sales Revenue Goods Net | $23.8K | $34.0K | $15.1K | $2.1K | $295.8K | $120.00 | $2.1K | $552.00 | $25.00 | $2.3K | $442.00 | $47.00 | $224.00 | $2.4K | ||||||||
| Comprehensive Income Net Of Tax | -$46.4K | -$146.6K | -$344.6K | -$235.7K | -$289.6K | -$178.0K | -$14.2K | -$176.1K | -$138.5K | -$122.9K | -$66.5K | |||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $0.00 | -$6.6K | $6.6K | -$6.5K | $23.3K | -$13.3K | -$12.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$387.8K | -$280.6K | -$197.8K | $22.2K | -$186.0K | -$594.6K | -$301.1K | |
| Cash And Cash Equivalents At Carrying Value | $4.9K | $711.00 | $1.1K | $82.00 | $33.00 | $4.00 | ||
| Retained Earnings Accumulated Deficit | -$5.8M | -$5.6M | -$4.9M | -$2.9M | -$2.9M | -$2.1M | ||
| Liabilities Current | $403.2K | $324.6K | $223.3K | $185.5K | $419.7K | $682.4K | ||
| Liabilities And Stockholders Equity | $15.4K | $44.0K | $25.6K | $207.7K | $233.7K | $87.8K | ||
| Common Stock Value | $2.5K | $1.3K | $377.00 | $10.1K | $65.4K | $19.7K | ||
| Assets Current | $15.1K | $43.7K | $25.6K | $1.1K | $27.1K | $87.8K | ||
| Assets | $15.4K | $44.0K | $25.6K | $207.7K | $233.7K | $87.8K | ||
| Accounts Payable And Accrued Liabilities Current | $94.9K | $154.7K | $144.6K | $123.2K | $296.4K | $384.5K | ||
| Liabilities | $403.2K | $324.6K | $223.3K | $185.5K | $419.7K | $682.4K | ||
| Cash And Cash Equivalents Period Increase Decrease | $18.5K | -$2.8K | $4.2K | -$365.00 | $994.00 | $49.00 | $29.00 | |
| Additional Paid In Capital Common Stock | $5.4M | $5.2M | $4.8M | $3.7M | $2.9M | $1.6M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$69.2K | -$68.0K | ||
| Debt Conversion Converted Instrument Amount1 | $6.2K | $4.1K | $54.8K | $131.8K | $54.3K | $246.6K | ||
| Convertible Notes Payable Current | $23.9K | $60.7K | $8.2K | |||||
| Cash Equivalents At Carrying Value | $20.5K | $2.1K | $4.9K | $711.00 | $1.1K | $82.00 | ||
| Notes Payable Current | $7.7K | $6.0K | $19.7K | $243.8K | ||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $300.00 | $300.00 | $206.6K | $206.6K | ||||
| Cash | $4.9K | $711.00 | $1.1K | $82.00 | $33.00 | $4.00 | ||
| Inventory Net | $8.4K | $0.00 | $24.9K | $87.8K | ||||
| Debt Instrument Convertible Beneficial Conversion Feature | $109.5K | -$173.0K | -$34.3K | |||||
| Accounts Receivable Net Current | $3.2K | |||||||
| Preferred Stock Value | $113.2K | $113.2K | ||||||
| Convertible Notes Payable | $201.4K | $138.2K | $71.0K | |||||
| Common Stock Shares Subscriptions | 23.0K | 23.0K | 34.4K | |||||
| Inventory Finished Goods | $87.8K | $82.2K | ||||||
| Notes Payable Related Parties Classified Current | $100.8K | $49.2K | ||||||
| Deferred Compensation Liability Current | -$17.4K | -$150.0K | ||||||
| Amortization Of Debt Discount Premium | $239.9K | $43.1K | $100.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$426.2K | -$449.3K | -$523.6K | -$495.4K | -$373.6K | -$216.7K | -$403.1K | -$361.8K | -$330.3K | -$332.3K | -$249.4K | -$222.5K | -$196.8K | $222.3K | $257.3K | -$108.4K | -$224.0K | -$158.8K | |||||||||
| Cash And Cash Equivalents At Carrying Value | $16.6K | $18.3K | $9.0K | $20.5K | $2.1K | $15.0K | $3.9K | $82.00 | $933.00 | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$6.2M | -$6.2M | -$6.3M | -$6.2M | -$6.1M | -$6.0M | -$5.9M | -$5.8M | -$5.7M | -$5.7M | -$5.2M | -$5.1M | -$2.9M | -$2.9M | -$2.9M | -$2.9M | -$2.9M | -$2.9M | -$2.9M | ||||||||
| Liabilities Current | $452.6K | $476.6K | $542.4K | $528.6K | $417.6K | $423.8K | $454.8K | $382.8K | $350.9K | $369.8K | $263.6K | $238.1K | $220.5K | $242.4K | $234.7K | $358.4K | $457.9K | $407.4K | $565.8K | ||||||||
| Liabilities And Stockholders Equity | $26.4K | $27.3K | $18.9K | $33.1K | $44.0K | $207.1K | $51.6K | $21.0K | $20.6K | $37.6K | $14.2K | $15.6K | $23.7K | $464.7K | $492.0K | $250.1K | $233.9K | $248.6K | $287.2K | ||||||||
| Common Stock Value | $4.5K | $4.0K | $3.4K | $3.3K | $3.0K | $2.8K | $2.5K | $2.2K | $2.1K | $1.8K | $29.9K | $24.1K | $21.4K | $174.8K | $156.9K | $116.6K | $74.3K | $67.1K | $41.2K | ||||||||
| Assets Current | $26.2K | $27.1K | $18.6K | $32.9K | $43.7K | $206.8K | $51.3K | $20.7K | $20.3K | $37.3K | $14.2K | $15.6K | $23.7K | $33.1K | $60.4K | $43.5K | $27.3K | $42.0K | $87.2K | ||||||||
| Assets | $26.4K | $27.3K | $18.9K | $33.1K | $44.0K | $207.1K | $51.6K | $21.0K | $20.6K | $37.6K | $14.2K | $15.6K | $23.7K | $464.7K | $492.0K | $250.1K | $233.9K | $248.6K | $287.2K | ||||||||
| Accounts Payable And Accrued Liabilities Current | $78.3K | $98.1K | $152.3K | $138.1K | $124.1K | $169.4K | $94.9K | $94.9K | $95.1K | $139.6K | $146.6K | $156.7K | $165.3K | $123.1K | $112.3K | $145.4K | $151.6K | $300.8K | $306.9K | ||||||||
| Liabilities | $452.6K | $476.6K | $542.4K | $528.6K | $417.6K | $423.8K | $454.8K | $382.8K | $369.8K | $263.6K | $238.1K | $220.5K | $242.4K | $234.7K | $358.4K | $457.9K | $407.4K | $565.8K | |||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$11.5K | -$109.00 | -$1.8K | -$711.00 | $1.7K | $14.9K | $49.00 | ||||||||||||||||||||
| Additional Paid In Capital Common Stock | $5.7M | $5.7M | $5.7M | $5.7M | $5.7M | $5.7M | $5.4M | $5.4M | $5.3M | $5.3M | $5.0M | $4.9M | $4.8M | $4.4M | $4.4M | $3.8M | $3.5M | $2.9M | $2.6M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.3K | -$75.8K | -$75.7K | -$62.7K | ||||||||
| Debt Conversion Converted Instrument Amount1 | $890.00 | $13.5K | $1.8K | $30.0K | $34.1K | ||||||||||||||||||||||
| Convertible Notes Payable Current | $112.2K | $112.2K | $112.2K | $112.2K | $74.8K | $106.5K | $147.5K | $100.8K | $88.0K | $74.1K | $50.7K | $109.3K | $73.8K | $47.5K | $71.0K | $91.7K | $108.5K | $63.2K | $79.7K | $24.3K | $10.0K | ||||||
| Cash Equivalents At Carrying Value | $16.6K | $18.3K | $9.0K | $23.6K | $27.8K | $1.9K | $8.8K | $4.2K | $3.0K | $879.00 | $442.00 | $0.00 | $269.00 | $16.5K | $2.8K | $277.00 | $220.00 | $15.0K | $3.9K | ||||||||
| Notes Payable Current | $10.0K | $15.0K | $5.0K | $5.0K | $5.0K | $36.0K | $6.1K | $6.1K | $6.1K | $6.1K | $7.8K | $7.7K | $7.7K | $6.0K | $6.0K | $12.3K | $12.1K | $21.0K | |||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $195.00 | $210.00 | $225.00 | $240.00 | $300.00 | $300.00 | $300.00 | $300.00 | $300.00 | $300.00 | $431.6K | $431.6K | $206.6K | $206.6K | $206.6K | $200.0K | |||||||||||
| Cash | $16.6K | $18.3K | $9.0K | $20.5K | $2.1K | $15.0K | $3.9K | $82.00 | $933.00 | ||||||||||||||||||
| Inventory Net | $6.4K | $8.3K | $8.3K | $9.7K | $11.7K | $12.5K | $12.9K | $15.1K | $23.7K | $27.9K | $43.9K | $83.3K | |||||||||||||||
| Debt Instrument Convertible Beneficial Conversion Feature | $0.00 | -$5.7K | -$42.1K | -$73.2K | |||||||||||||||||||||||
| Accounts Receivable Net Current | $9.1K | $8.8K | $9.6K | $11.7K | $11.7K | $168.3K | $3.2K | $2.0K | |||||||||||||||||||
| Preferred Stock Value | $113.2K | $113.2K | $113.2K | $113.2K | $113.2K | $113.2K | $113.2K | $113.2K | $113.2K | $113.2K | |||||||||||||||||
| Convertible Notes Payable | $159.2K | $161.8K | $163.8K | $164.7K | $145.6K | $85.4K | $206.3K | $193.8K | $175.7K | $171.7K | |||||||||||||||||
| Common Stock Shares Subscriptions | 23.0K | 23.0K | 23.0K | 23.0K | 23.0K | 23.0K | 23.0K | 23.0K | 23.0K | 23.0K | |||||||||||||||||
| Inventory Finished Goods | -$83.3K | $90.5K | -$89.8K | $84.8K | $85.6K | ||||||||||||||||||||||
| Notes Payable Related Parties Classified Current | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $56.4K | $49.2K | $44.3K | |||||||||||||||||||
| Deferred Compensation Liability Current | -$65.4K | -$15.4K | -$92.4K | -$182.8K | -$244.9K | -$187.5K | |||||||||||||||||||||
| Amortization Of Debt Discount Premium | $6.9K | $39.9K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$39.3K | -$115.8K | -$135.4K | -$132.0K | -$83.7K | -$23.3K | -$109.6K |
| Net Cash Provided By Used In Financing Activities | $57.5K | $113.2K | $139.5K | $131.6K | $78.6K | $20.8K | $121.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$128.9K | $59.7K | $21.8K | $32.4K | $21.9K | $89.6K | $102.4K |
| Increase Decrease In Inventories | $8.4K | -$8.4K | -$10.5K | $24.9K | $897.00 | ||
| Increase Decrease In Accounts Receivable | $8.6K | $4.6K | -$2.0K | ||||
| Increase Decrease In Prepaid Expense | -$643.00 | -$37.6K | |||||
| Proceeds From Notes Payable | $128.5K | $113.2K | $139.5K | $134.2K | |||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $6.1K | $2.6K | -$11.7K | ||||
| Proceeds From Repayments Of Other Debt | $78.6K | $8.2K | |||||
| Net Cash Provided By Used In Investing Activities | $250.00 | -$250.00 | |||||
| Proceeds From Repayments Of Short Term Debt | -$1.4K | $114.7K | |||||
| Share Based Compensation | $1.9K | $32.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2017 | Q3 2016 | Q1 2016 | Q1 2015 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$11.5K | -$48.6K | -$69.1K | -$711.00 | -$50.3K | -$1.0K | -$7.9K | |||||
| Net Cash Provided By Used In Financing Activities | $48.5K | $67.3K | $0.00 | $52.0K | $16.0K | $8.5K | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $14.7K | $10.1K | $387.00 | $21.5K | $23.3K | $6.7K | $52.0K | |||||
| Increase Decrease In Inventories | -$60.00 | $12.5K | -$1.2K | |||||||||
| Increase Decrease In Accounts Receivable | -$2.1K | $250.00 | ||||||||||
| Increase Decrease In Prepaid Expense | -$639.00 | $36.4K | -$17.4K | $0.00 | $40.7K | |||||||
| Proceeds From Notes Payable | $48.5K | $67.3K | $0.00 | |||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$33.00 | -$488.00 | ||||||||||
| Proceeds From Repayments Of Other Debt | $40.0K | $16.0K | $9.0K | |||||||||
| Net Cash Provided By Used In Investing Activities | ||||||||||||
| Proceeds From Repayments Of Short Term Debt | $12.0K | -$514.00 | ||||||||||
| Share Based Compensation | $1.9K | $214.6K | $282.2K | $208.3K | $18.1K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 2.8M | 2.0M | 675.2K | 297.2K | 7.6M | 36.3M | 18.2M |
| Earnings Per Share Basic | $-0.15 | $-0.14 | $-0.99 | $-4.91 | $-0.05 | $-0.02 | $-0.03 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 90.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 2.5M | 1.3M | 377.5K | 10.1M | 65.4M | 19.7M | |
| Common Stock Shares Issued | 2.5M | 1.3M | 377.5K | 10.1M | 65.4M | 19.7M | |
| Preferred Stock Shares Authorized | 1.0K | 1.0K | 1.0K | ||||
| Preferred Stock Shares Outstanding | 1.0K | 1.0K | 0.00 | ||||
| Preferred Stock Shares Issued | 1.0K | 1.0K | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 4.1M | 3.7M | 3.3M | 2.9M | 2.6M | 2.5M | 2.1M | 1.9M | 1.6M | 569.4K | 470.8K | 557.7K | 16.8M | 13.3M | 10.9M | 73.8M | 67.2M | 67.2M | 32.5M | 19.7M | 18.5M | ||
| Earnings Per Share Basic | $0.00 | $0.01 | $-0.01 | $-0.06 | $-0.03 | $-0.01 | $-0.02 | $-0.03 | $-0.08 | $-0.18 | $-0.22 | $-0.08 | $-0.01 | $-0.03 | $-0.02 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | $0.00 | ||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 90.0M | 90.0M | 90.0M | 75.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 4.5M | 4.0M | 3.4M | 3.3M | 3.0M | 2.8M | 2.5M | 2.2M | 2.1M | 1.8M | 29.9M | 24.1M | 21.4M | 174.8M | 156.9M | 116.6M | 74.3M | 67.1M | 41.2M | ||||
| Common Stock Shares Issued | 4.5M | 4.0M | 3.4M | 3.3M | 3.0M | 2.8M | 2.5M | 2.2M | 2.1M | 1.8M | 29.9M | 24.1M | 21.4M | 174.8M | 156.9M | 116.6M | 74.3M | 67.1M | 41.2M | ||||
| Preferred Stock Shares Authorized | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | |||||||||||||
| Preferred Stock Shares Outstanding | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 0.00 | 1.0K | |||||||||||||
| Preferred Stock Shares Issued | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K | 0.00 | 1.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Professional Fees | $52.1K | $8.9K | $504.2K | ||||
| Issuance Of Stock And Warrants For Services Or Claims | $1.9K | $32.8K | $372.7K | $925.7K | $259.2K | $701.0K | $336.1K |
| Prepaid Expense Current | $1.3K | $38.9K | $0.00 | $27.0K | |||
| Salaries And Wages | $504.2K | $1.0M | $355.7K | $788.9K | $490.7K | ||
| Stock Issued1 | $4.3K | $6.4K | $47.8K | $152.7K | |||
| Stock Issued During Period Value Issued For Services | $1.9K | $26.8K | $184.2K | ||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $568.7K | $169.6K | |||||
| Due To Related Parties Current | $1.7K | $1.6K | $49.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $13.7K | $10.1K | $16.3K | $14.7K | $9.5K | $9.4K | $11.1K | $33.5K | $61.4K | $63.2K | $63.4K | $33.6K | $8.5K | ||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $6.0K | $17.4K | $160.7K | $49.6K | |||||||||||||||||||
| Prepaid Expense Current | $417.00 | $639.00 | $1.6K | $2.1K | $37.7K | $4.1K | $21.5K | $467.00 | $5.0K | $40.7K | $27.0K | $27.0K | |||||||||||
| Salaries And Wages | $63.2K | $63.4K | $33.6K | $214.6K | $282.2K | $183.3K | $208.3K | $5.7K | $157.0K | $101.4K | $18.9K | ||||||||||||
| Stock Issued1 | $4.3K | $0.00 | $41.5K | ||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $906.00 | $10.0K | |||||||||||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $2.1M | $2.0M | $1.3M | $1.1M | $804.3K | $657.3K | $177.3K | ||||||||||||||||
| Due To Related Parties Current | $1.7K | $1.7K | $1.6K | $1.6K | $1.6K |
Most recent annual filing with the SEC: March 29, 2017
Data sourced from SEC EDGAR public filings as of August 5, 2026.